Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00022381
DRKS00022381
Not yet recruiting
Not Applicable

Observational post-market surveillance registry including subjects treated with biodegradable magnesium-based implants specific for the intended use

Syntellix AG0 sites1,000 target enrollmentJuly 7, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAll MAGNEZIX® implants with marketing approval. Conditions strictly follow the instructions for use (IFU)

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
All MAGNEZIX® implants with marketing approval. Conditions strictly follow the instructions for use (IFU)
Sponsor
Syntellix AG
Enrollment
1000
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 7, 2020
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Indication for treatment with MAGNEZIX® product according to the IFU.
  • •\- Age \= 18 years.
  • •\- Written informed consent for all individual patient data entered into the database.

Exclusion Criteria

  • •\- Exclusion according to the IFU.
  • •\- Known allergies against any components of the implant.
  • •\- Participation in an interventional orthopedic or surgical trial prior to surgery.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Not Applicable
Prospective, Post Market Surveillance Q3-registry (POLARIS)Peripheral Artery Disease
NCT02307292QualiMed Innovative Medizinprodukte GmbH250
Completed
Phase 4
A post-marketing surveillance registry of the BioMatrix coronary stent in diabetic patients.Health Condition 1: null- Coronary Artery Occlusion
CTRI/2011/10/002088Biosensors Europe SA Morges Switzerland1,000
Recruiting
Not Applicable
Rezum System Post Market surveillancePatients with bothersome urinary symptoms associated with BPH.
JPRN-UMIN000048675Boston Scientific Japan K.K.100
Completed
Not Applicable
ational, multicentre post market surveillance study on anterior pelvic prolapse reconstruction with a titanium-coated polypropylene mesh (TiLOOP® PRO A)N81N81.1Female genital prolapseCystocele
DRKS00010001pfm medical ag54
Completed
Not Applicable
Prospective Multi-Center Post Market Surveillance of the Efficacy and the Safety of the DuraSeal Dural Sealant System in a CraniotomyPatients scheduled for craniotomy that entails dural incision.
JPRN-UMIN000007147Covidien Japan Inc.140